• Consensus Rating: Buy
  • Consensus Price Target: $602.44
  • Forecasted Upside: 21.31%
  • Number of Analysts: 15
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 14 Buy Ratings
  • 0 Strong Buy Ratings
$496.60
▼ -3.47 (-0.69%)

This chart shows the closing price for HUM by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Humana Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HUM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HUM

Analyst Price Target is $602.44
▲ +21.31% Upside Potential
This price target is based on 15 analysts offering 12 month price targets for Humana in the last 3 months. The average price target is $602.44, with a high forecast of $652.00 and a low forecast of $510.00. The average price target represents a 21.31% upside from the last price of $496.60.

This chart shows the closing price for HUM for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 15 investment analysts is to buy stock in Humana. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 14 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/4/2021
  • 0 strong buy ratings
  • 15 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/4/2022
  • 0 strong buy ratings
  • 15 buy ratings
  • 3 hold ratings
  • 0 sell ratings
6/2/2022
  • 0 strong buy ratings
  • 15 buy ratings
  • 2 hold ratings
  • 0 sell ratings
8/31/2022
  • 0 strong buy ratings
  • 12 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/29/2022
  • 0 strong buy ratings
  • 14 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/27/2023
  • 0 strong buy ratings
  • 15 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/28/2023
  • 0 strong buy ratings
  • 14 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/28/2023

Latest Recommendations

  • 0 strong buy ratings
  • 14 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/27/2023Deutsche Bank AktiengesellschaftBoost Target$562.00 ➝ $568.00Low
4/27/2023SVB SecuritiesLower Target$640.00 ➝ $600.00Low
4/20/2023Cantor FitzgeraldInitiated CoverageOverweight$597.00Low
4/13/2023Truist FinancialBoost TargetHold$560.00 ➝ $590.00Low
4/11/2023Morgan StanleyBoost TargetOverweight$620.00 ➝ $637.00Low
2/28/2023Deutsche Bank AktiengesellschaftLower TargetBuy$575.00 ➝ $562.00Low
2/7/2023Truist FinancialLower TargetHold$580.00 ➝ $560.00Low
2/6/2023CowenLower TargetOutperform$647.00 ➝ $581.00Low
2/6/2023Credit Suisse GroupLower TargetOutperform$635.00 ➝ $575.00Low
2/3/2023StephensLower TargetOverweight$625.00 ➝ $590.00Low
2/2/2023UBS GroupLower TargetBuy$645.00 ➝ $620.00Low
1/6/2023JPMorgan Chase & Co.Lower TargetOverweight$630.00 ➝ $625.00Low
12/13/2022The Goldman Sachs GroupUpgradeNeutral ➝ Buy$575.00 ➝ $652.00Low
11/10/2022MizuhoBoost TargetBuy$529.00 ➝ $615.00Low
11/8/2022Wells Fargo & CompanyBoost Target$558.00 ➝ $610.00Low
11/7/2022CowenBoost Target$547.00 ➝ $647.00Low
11/7/2022CowenBoost Target$547.00 ➝ $647.00Low
11/3/2022The Goldman Sachs GroupBoost TargetNeutral$522.00 ➝ $575.00Low
11/3/2022SVB LeerinkBoost TargetOutperform$540.00 ➝ $640.00Low
11/3/2022Truist FinancialBoost Target$570.00 ➝ $650.00Low
11/3/2022Royal Bank of CanadaBoost TargetOutperform$560.00 ➝ $637.00Low
11/3/2022Credit Suisse GroupBoost TargetOutperform$548.00 ➝ $635.00Low
10/31/2022Morgan StanleyBoost TargetOverweight$549.00 ➝ $620.00Low
10/26/2022Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$514.00 ➝ $576.00Low
9/20/2022Royal Bank of CanadaBoost TargetOutperform$541.00 ➝ $544.00Low
9/20/2022Morgan StanleyUpgradeEqual Weight ➝ Overweight$494.00 ➝ $549.00Low
9/16/2022Truist FinancialBoost TargetHold$550.00 ➝ $570.00Low
9/16/2022OppenheimerBoost TargetOutperform$520.00 ➝ $550.00Low
8/9/2022CowenBoost Target$547.00Low
8/2/2022Morgan StanleyBoost TargetEqual Weight$453.00 ➝ $494.00Low
7/28/2022SVB LeerinkBoost TargetOutperform$535.00 ➝ $540.00Low
7/28/2022Deutsche Bank AktiengesellschaftBoost Target$450.00 ➝ $514.00Low
7/28/2022OppenheimerBoost TargetOutperform$510.00 ➝ $520.00Low
7/19/2022Credit Suisse GroupSet Target$548.00Low
7/14/2022Truist FinancialBoost TargetHold$490.00 ➝ $550.00Low
6/16/2022Loop CapitalInitiated CoverageBuy$510.00Medium
5/26/2022Sanford C. BernsteinInitiated CoverageMarket Perform$480.00 ➝ $506.00Medium
5/25/2022Wells Fargo & CompanyBoost TargetOverweight$512.00 ➝ $514.00Low
4/28/2022Wells Fargo & CompanyBoost Target$491.00 ➝ $512.00High
4/13/2022UBS GroupUpgradeNeutral ➝ Buy$486.00 ➝ $520.00Medium
4/7/2022Truist FinancialBoost Target$460.00 ➝ $490.00High
3/9/2022Morgan StanleyBoost TargetEqual Weight$410.00 ➝ $436.00Low
2/3/2022Deutsche Bank AktiengesellschaftBoost Target$418.00 ➝ $435.00Medium
2/3/2022SVB LeerinkLower TargetOutperform$528.00 ➝ $525.00Medium
1/11/2022Sanford C. BernsteinLower Target$470.00 ➝ $431.00Low
1/7/2022MizuhoReiterated RatingBuy$500.00High
1/7/2022UBS GroupReiterated RatingHold$486.00High
1/7/2022BMO Capital MarketsLower Target$490.00 ➝ $415.00Low
1/7/2022Wells Fargo & CompanyLower Target$529.00 ➝ $452.00Low
1/7/2022Deutsche Bank AktiengesellschaftLower TargetHold ➝ Hold$476.00 ➝ $418.00Low
1/7/2022Morgan StanleyLower TargetEqual Weight$530.00 ➝ $410.00High
1/7/2022BarclaysLower TargetOverweight$540.00 ➝ $490.00High
1/6/2022Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$492.00 ➝ $529.00High
1/5/2022Truist FinancialBoost TargetHold ➝ Hold$500.00 ➝ $520.00Low
12/16/2021Morgan StanleyDowngradeOverweight ➝ Equal Weight$559.00 ➝ $530.00Low
12/14/2021The Goldman Sachs GroupInitiated CoverageNeutral$472.00High
11/10/2021MizuhoBoost TargetBuy$480.00 ➝ $500.00Low
11/9/2021Deutsche Bank AktiengesellschaftBoost TargetHold$427.00 ➝ $456.00Low
11/9/2021CitigroupBoost TargetBuy$510.00 ➝ $528.00Low
11/4/2021Bank of AmericaBoost TargetBuy$505.00 ➝ $530.00Low
11/4/2021Morgan StanleyBoost TargetOverweight$513.00 ➝ $559.00Low
11/4/2021OppenheimerBoost TargetOutperform$480.00 ➝ $510.00Medium
11/4/2021Credit Suisse GroupBoost TargetOutperform$500.00 ➝ $513.00Medium
11/4/2021SVB LeerinkBoost TargetOutperform$494.00 ➝ $528.00Medium
11/4/2021Royal Bank of CanadaBoost TargetOutperform$479.00 ➝ $525.00Medium
11/4/2021BarclaysBoost TargetOverweight$500.00 ➝ $540.00Medium
9/27/2021SVB LeerinkInitiated CoverageOutperform$494.00Low
9/9/2021CowenInitiated CoverageOutperform$479.00High
9/9/2021BarclaysInitiated CoverageOverweight$500.00Low
8/31/2021Morgan StanleyBoost TargetOverweight$500.00 ➝ $513.00Low
7/9/2021Seaport Res PtnReiterated RatingNeutralLow
7/9/2021JPMorgan Chase & Co.Boost TargetOverweight$440.00 ➝ $514.00Low
5/24/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$472.00N/A
5/18/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$472.00Medium
4/29/2021CitigroupBoost Target$496.00 ➝ $510.00Low
4/29/2021OppenheimerBoost TargetOutperform$460.00 ➝ $480.00Low
4/29/2021MizuhoBoost TargetBuy$462.00 ➝ $480.00Medium
1/6/2021ArgusBoost TargetBuy$430.00 ➝ $450.00N/A
1/4/2021Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$429.00 ➝ $479.00N/A
11/30/2020SVB LeerinkLower TargetSell ➝ Outperform$505.00 ➝ $500.00High
11/4/2020Smith Barney CitigroupBoost Target$469.00 ➝ $496.00Low
11/4/2020Credit Suisse GroupBoost TargetOutperform$423.00 ➝ $465.00Low
11/4/2020OppenheimerBoost TargetOutperform$440.00 ➝ $460.00Low
11/4/2020StephensBoost TargetOverweight$450.00 ➝ $490.00Low
10/13/2020Truist FinancialBoost Target$455.00 ➝ $475.00Low
10/1/2020Sanford C. BernsteinInitiated CoverageMarket Perform$459.00Medium
10/1/2020Piper SandlerBoost TargetOverweight$473.00 ➝ $495.00Low
9/10/2020Deutsche Bank AktiengesellschaftBoost TargetHold$397.00 ➝ $431.00High
8/18/2020JPMorgan Chase & Co.Boost TargetOverweight$394.00 ➝ $452.00Low
8/17/2020Royal Bank of CanadaBoost TargetSector Perform$388.00 ➝ $420.00Low
8/10/2020StephensBoost TargetOverweight$433.00 ➝ $450.00Low
8/7/2020MizuhoBoost TargetBuy$420.00 ➝ $462.00High
8/6/2020Credit Suisse GroupReiterated RatingBuyLow
8/6/2020Piper SandlerBoost TargetOverweight$442.00 ➝ $473.00Medium
8/6/2020OppenheimerBoost TargetOutperform$425.00 ➝ $440.00Low
8/6/2020SVB LeerinkBoost TargetOutperform$465.00 ➝ $496.00Medium
7/1/2020SVB LeerinkInitiated CoverageOutperform$465.00Low
6/18/2020Deutsche Bank AktiengesellschaftLower TargetHold$421.00 ➝ $397.00Low
6/17/2020Cantor FitzgeraldBoost Target$405.00 ➝ $410.00Medium
6/16/2020CowenReiterated RatingOutperform ➝ Market Perform$410.00Medium
6/5/2020The Goldman Sachs GroupInitiated CoverageBuy$510.00Medium
5/21/2020SunTrust BanksBoost TargetHold$400.00 ➝ $440.00Low
5/4/2020MizuhoBoost TargetBuy$405.00 ➝ $420.00Low
4/30/2020CSFBBoost TargetOutperform$400.00 ➝ $423.00Medium
4/30/2020Credit Suisse GroupBoost TargetOutperform$400.00 ➝ $423.00High
4/30/2020CitigroupBoost TargetBuy$424.00 ➝ $435.00Medium
4/30/2020Morgan StanleyBoost TargetOverweight$375.00 ➝ $500.00Medium
4/30/2020OppenheimerBoost TargetOutperform$400.00 ➝ $425.00Medium
4/13/2020Morgan StanleyBoost TargetOverweight$343.00 ➝ $375.00Medium
3/29/2020BarclaysReiterated RatingBuyHigh
3/27/2020Morgan StanleyLower TargetOverweight$460.00 ➝ $343.00Medium
2/19/2020Royal Bank of CanadaReiterated RatingHold$370.00Low
2/18/2020Deutsche Bank AktiengesellschaftBoost TargetHold$363.00 ➝ $433.00Medium
2/14/2020MizuhoReiterated RatingBuy$405.00N/A
2/6/2020Morgan StanleyBoost TargetOverweight$457.00 ➝ $460.00Low
2/6/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$319.00 ➝ $363.00Medium
2/6/2020MizuhoBoost TargetBuy$400.00 ➝ $405.00Medium
2/5/2020Cantor FitzgeraldBoost TargetOverweight$345.00 ➝ $400.00Low
1/27/2020The Goldman Sachs GroupReiterated RatingBuy$425.00Medium
1/23/2020UBS GroupBoost TargetNeutral$321.00 ➝ $406.00Low
1/8/2020Credit Suisse GroupBoost TargetOutperform$378.00 ➝ $400.00High
1/3/2020JPMorgan Chase & Co.Boost TargetOverweight$437.00 ➝ $448.00Medium
1/3/2020The Goldman Sachs GroupReiterated RatingBuy ➝ Buy$425.00 ➝ $425.00Medium
12/20/2019JPMorgan Chase & Co.Boost TargetOverweight$322.00 ➝ $437.00Low
12/17/2019SunTrust BanksReiterated RatingHold$370.00Low
12/11/2019Wells Fargo & CompanyReiterated RatingOverweight$338.00 ➝ $400.00Low
12/6/2019BarclaysBoost TargetOverweight$327.00 ➝ $358.00Low
11/20/2019ArgusBoost TargetBuy$370.00Low
11/18/2019Morgan StanleyReiterated RatingBuy$337.00 ➝ $360.00Low
11/15/2019SunTrust BanksBoost TargetPositive ➝ Hold$350.00High
11/7/2019SunTrust BanksBoost TargetHold$335.00High
10/17/2019MizuhoInitiated CoverageBuy$316.00High
9/30/2019BMO Capital MarketsDowngradeOutperform ➝ Market Perform$345.00 ➝ $290.00Low
9/26/2019Morgan StanleyLower TargetOverweight$342.00 ➝ $337.00High
9/12/2019Deutsche Bank AktiengesellschaftInitiated CoverageHold$300.00High
8/23/2019Morgan StanleyBoost TargetOverweight$315.00 ➝ $342.00Medium
8/12/2019Cantor FitzgeraldUpgradeNeutral ➝ Overweight$300.00 ➝ $345.00Medium
8/1/2019JPMorgan Chase & Co.Boost TargetOverweight$288.00 ➝ $322.00Low
8/1/2019Piper Jaffray CompaniesBoost TargetOverweight$315.00 ➝ $341.00Low
8/1/2019UBS GroupBoost TargetNeutral$266.00 ➝ $317.00Low
8/1/2019SunTrust BanksBoost TargetHold$340.00Low
7/12/2019Morgan StanleyLower TargetOverweight$331.00 ➝ $315.00High
5/2/2019SunTrust BanksLower Target$300.00Low
5/2/2019OppenheimerLower TargetOutperform$373.00 ➝ $350.00Low
5/2/2019Morgan StanleySet TargetBuy$331.00Low
5/2/2019Credit Suisse GroupLower TargetOutperform$352.00 ➝ $315.00Low
5/2/2019CitigroupLower TargetBuy ➝ Buy$362.00 ➝ $302.00Low
4/23/2019UBS GroupInitiated CoverageNeutral ➝ Neutral$266.00Medium
4/17/2019BarclaysLower TargetOverweight ➝ Overweight$351.00 ➝ $327.00Low
2/7/2019CitigroupLower TargetBuy ➝ Buy$397.00 ➝ $362.00Low
2/7/2019Credit Suisse GroupLower TargetOutperform$390.00 ➝ $352.00Low
1/14/2019StephensInitiated CoverageOverweight$336.00Low
1/11/2019CowenUpgradeMarket Perform ➝ Outperform$275.02High
1/6/2019BarclaysReiterated RatingBuy$351.00Low
1/2/2019Cantor FitzgeraldReiterated RatingHold$325.00High
12/20/2018JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$283.00Medium
11/8/2018Morgan StanleyBoost TargetOverweight ➝ Buy$400.00 ➝ $418.00Low
11/8/2018BMO Capital MarketsSet TargetBuy$390.00Low
11/8/2018Royal Bank of CanadaBoost TargetSector Perform ➝ Sector Perform$318.00 ➝ $349.00Low
11/8/2018Credit Suisse GroupBoost TargetOutperform ➝ Outperform$370.00 ➝ $390.00Low
11/8/2018Bank of AmericaBoost TargetBuy$400.00 ➝ $415.00Medium
11/8/2018Jefferies Financial GroupBoost TargetBuy ➝ Buy$388.00 ➝ $410.00High
9/19/2018SunTrust BanksBoost TargetHold$380.00Low
9/17/2018CowenInitiated CoverageMarket Perform$372.00Low
9/13/2018BarclaysInitiated CoverageOverweight ➝ Overweight$370.00Medium
9/4/2018Credit Suisse GroupBoost TargetOutperform$350.00 ➝ $370.00Low
9/4/2018ArgusBoost TargetBuy$375.00Low
8/24/2018Piper Jaffray CompaniesBoost TargetOverweight$355.00 ➝ $380.00Low
8/2/2018SunTrust BanksReiterated RatingHold$350.00Low
8/2/2018Piper Jaffray CompaniesReiterated RatingBuy$355.00Low
8/2/2018Bank of AmericaBoost TargetBuy ➝ Buy$338.00 ➝ $375.00Low
8/2/2018Morgan StanleyBoost TargetOverweight ➝ Overweight$362.00 ➝ $365.00Low
8/2/2018Jefferies Financial GroupBoost TargetBuy ➝ Buy$356.00 ➝ $372.00Low
8/2/2018Royal Bank of CanadaReiterated RatingHold$318.00Low
7/12/2018Morgan StanleyInitiated CoverageOverweight$362.00Low
7/6/2018Piper Jaffray CompaniesBoost TargetOverweight$326.00 ➝ $350.00Medium
6/25/2018BMO Capital MarketsBoost TargetOutperform ➝ Outperform$328.00 ➝ $355.00Low
6/1/2018CitigroupReiterated RatingBuy ➝ Buy$280.00 ➝ $340.00Low
(Data available from 5/28/2018 forward)

News Sentiment Rating

0.64 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 32 very positive mentions
  • 27 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
10/30/2022
  • 22 very positive mentions
  • 15 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
11/29/2022
  • 18 very positive mentions
  • 13 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
12/29/2022
  • 14 very positive mentions
  • 16 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
1/28/2023
  • 26 very positive mentions
  • 9 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
2/27/2023
  • 23 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
3/29/2023
  • 34 very positive mentions
  • 36 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
4/28/2023
  • 19 very positive mentions
  • 32 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
5/28/2023

Current Sentiment

  • 19 very positive mentions
  • 32 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Humana logo
Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.
Read More

Today's Range

Now: $496.60
Low: $495.27
High: $503.27

50 Day Range

MA: $513.07
Low: $483.41
High: $535.96

52 Week Range

Now: $496.60
Low: $418.70
High: $571.30

Volume

648,843 shs

Average Volume

703,121 shs

Market Capitalization

$62.05 billion

P/E Ratio

20.17

Dividend Yield

0.71%

Beta

0.72

Frequently Asked Questions

What sell-side analysts currently cover shares of Humana?

The following sell-side analysts have issued reports on Humana in the last twelve months: Cantor Fitzgerald, Cowen Inc, Cowen Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Loop Capital, Mizuho, Morgan Stanley, Oppenheimer Holdings Inc., Royal Bank of Canada, Stephens, StockNews.com, SVB Leerink LLC, SVB Securities, The Goldman Sachs Group, Inc., TheStreet, Truist Financial Co., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for HUM.

What is the current price target for Humana?

18 Wall Street analysts have set twelve-month price targets for Humana in the last year. Their average twelve-month price target is $602.44, suggesting a possible upside of 21.3%. The Goldman Sachs Group, Inc. has the highest price target set, predicting HUM will reach $652.00 in the next twelve months. Loop Capital has the lowest price target set, forecasting a price of $510.00 for Humana in the next year.
View the latest price targets for HUM.

What is the current consensus analyst rating for Humana?

Humana currently has 1 hold rating and 14 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe HUM will outperform the market and that investors should add to their positions of Humana.
View the latest ratings for HUM.

What other companies compete with Humana?

How do I contact Humana's investor relations team?

Humana's physical mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider's listed phone number is (502) 580-1000 and its investor relations email address is [email protected]. The official website for Humana is www.humana.com. Learn More about contacing Humana investor relations.